Evidence map›Paper›PMID 36644309›Full record

ArticleSensing and Bio-Sensing Research2022

Validation of the novel transdermal arterial gasotransmitter sensor (TAGS

B T Matheson, R B Osofsky, D M Friedrichsen, B J Brooks, R M Clark, N L Kanagy, R Shekarriz

Open access · goldAbstract read
In one paragraph

Article in Sensing and Bio-Sensing Research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

B T MathesonSchool of Medicine, University of New Mexico, Albuquerque, NM, United States of America.
R B OsofskySchool of Medicine, University of New Mexico, Albuquerque, NM, United States of America.
D M FriedrichsenExhalix, LLC, Albuquerque, NM, United States of America.
B J BrooksExhalix, LLC, Albuquerque, NM, United States of America.
R M ClarkSchool of Medicine, University of New Mexico, Albuquerque, NM, United States of America.
N L KanagySchool of Medicine, University of New Mexico, Albuquerque, NM, United States of America.
R ShekarrizExhalix, LLC, Albuquerque, NM, United States of America.
University of New Mexico · US

Funding

Transdermal H2S Sensing Device for Monitoring Peripheral Artery DiseaseR44HL121871 · NHLBI · EXHALIX, LLC · PI KANAGY, NANCY L, SHEKARRIZ, REZA · 2018 to 2019
$1.5M
Transdermal H2S Sensing Device for Monitoring Peripheral Artery DiseaseSB1HL121871 · NHLBI · EXHALIX, LLC · PI SHEKARRIZ, REZA · 2022 to 2022
$500k
Transdermal H2S Sensing Device for Monitoring Peripheral Artery DiseaseR41HL121871 · NHLBI · EXHALIX, LLC · PI KANAGY, NANCY L, SHEKARRIZ, REZA · 2014 to 2014
$216k
NHLBI NIH HHS R41 HL121871NHLBI NIH HHS R44 HL121871NHLBI NIH HHS SB1 HL121871
6 · The paper itself

Abstract

A novel non-invasive system has been developed to measure transdermally emitted hydrogen sulfide (H

Indexed as

BiosensorElectrochemicalH2SMedical deviceTAGS

Identifiers

PMID36644309
PMCPMC9835717
OpenAlexW4294204071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.